BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4043264)

  • 1. Purification of human urinary erythropoietin on controlled-pore glass and silicic acid.
    Zucali JR; Sulkowski E
    Exp Hematol; 1985 Sep; 13(8):833-7. PubMed ID: 4043264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of human erythropoietin for tissue culture.
    Cutler RL; Johnson GR; Nicola NA
    Exp Hematol; 1985 Sep; 13(8):796-801. PubMed ID: 4043260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues.
    Dehnes Y; Lamon S; Lönnberg M
    J Pharm Biomed Anal; 2010 Dec; 53(4):1028-32. PubMed ID: 20656433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
    Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
    Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient purification and preconcentration of erythropoietin in human urine by reusable immunoaffinity column.
    Mi J; Wang S; Ding X; Guo Z; Zhao M; Chang W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 843(1):125-30. PubMed ID: 16790370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and bioactivity of recombinant canine erythropoietin.
    MacLeod JN; Tetreault JW; Lorschy KA; Gu DN
    Am J Vet Res; 1998 Sep; 59(9):1144-8. PubMed ID: 9736393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin and its mode of action.
    Goldwasser E
    Blood Cells; 1984; 10(2-3):147-62. PubMed ID: 6100437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The preparation and identification of anti-erythropoietin monoclonal antibodies].
    Jiang M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):138-42. PubMed ID: 8242822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of murine erythropoietin.
    Cutler RL; Johnson GR; Nicola NA
    Exp Hematol; 1985 Oct; 13(9):899-905. PubMed ID: 4043266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of erythropoietin from human plasma samples using an immunoaffinity well plate.
    Mallorquí J; Llop E; de Bolòs C; Gutiérrez-Gallego R; Segura J; Pascual JA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2117-22. PubMed ID: 20630810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sialylation-sensitive cell-based in vitro bioassay for erythropoietin; incorporation of the galactose-binding Erythrina crista-galli lectin.
    Liefooghe EC; Tiplady R; Gerson P; Lloyd P; Heath A; Bristow AF
    Biologicals; 2005 Sep; 33(3):161-7. PubMed ID: 16084108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin enhances immune responses in mice.
    Katz O; Gil L; Lifshitz L; Prutchi-Sagiv S; Gassmann M; Mittelman M; Neumann D
    Eur J Immunol; 2007 Jun; 37(6):1584-93. PubMed ID: 17458859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of purified erythropoietin by high performance liquid chromatography.
    Lange RD; Andrews RB; Trent DJ; Reyniers JP; Draganac PS; Farkas WR
    Blood Cells; 1984; 10(2-3):305-14. PubMed ID: 6543653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary erythropoietin. I. Preparation of crude erythropoietin and its biological activity.
    Kaneko F; Tajiri M; Matsubara T; Miyake T; Kawakita Y
    Kumamoto Med J; 1971 Jun; 24(2):95-101. PubMed ID: 5143406
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
    J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human urinary erythropoietin: preparation with high potency.
    Matsushita J; Kawakita M; Shibuya K; Koishihara Y; Sakaguchi M; Takatsuki A
    Acta Haematol; 1990; 84(4):169-74. PubMed ID: 2125780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells.
    Lifshitz L; Prutchi-Sagiv S; Avneon M; Gassmann M; Mittelman M; Neumann D
    Mol Immunol; 2009 Feb; 46(4):713-21. PubMed ID: 19027957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1.
    Rui T; Feng Q; Lei M; Peng T; Zhang J; Xu M; Abel ED; Xenocostas A; Kvietys PR
    Cardiovasc Res; 2005 Feb; 65(3):719-27. PubMed ID: 15664399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.